JAK/STAT pathway inhibition overcomes IL7-induced glucocorticoid resistance in a subset of human T-cell acute lymphoblastic leukemias. Read more about JAK/STAT pathway inhibition overcomes IL7-induced glucocorticoid resistance in a subset of human T-cell acute lymphoblastic leukemias.
Genetics of ancestry-specific risk for relapse in acute lymphoblastic leukemia. Read more about Genetics of ancestry-specific risk for relapse in acute lymphoblastic leukemia.
Inhibition of the Gab2/PI3K/mTOR signaling ameliorates myeloid malignancy caused by Ptpn11 (Shp2) gain-of-function mutations. Read more about Inhibition of the Gab2/PI3K/mTOR signaling ameliorates myeloid malignancy caused by Ptpn11 (Shp2) gain-of-function mutations.
PR1 peptide vaccine induces specific immunity with clinical responses in myeloid malignancies. Read more about PR1 peptide vaccine induces specific immunity with clinical responses in myeloid malignancies.
MLL rearrangements impact outcome in HOXA-deregulated T-lineage acute lymphoblastic leukemia: a Children's Oncology Group Study. Read more about MLL rearrangements impact outcome in HOXA-deregulated T-lineage acute lymphoblastic leukemia: a Children's Oncology Group Study.
Targeting the PI3K/Akt pathway in murine MDS/MPN driven by hyperactive Ras. Read more about Targeting the PI3K/Akt pathway in murine MDS/MPN driven by hyperactive Ras.
Immunosuppressive human anti-CD83 monoclonal antibody depletion of activated dendritic cells in transplantation. Read more about Immunosuppressive human anti-CD83 monoclonal antibody depletion of activated dendritic cells in transplantation.
Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies. Read more about Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies.
IL10 receptor is a novel therapeutic target in DLBCLs. Read more about IL10 receptor is a novel therapeutic target in DLBCLs.
You eat what you are: autophagy inhibition as a therapeutic strategy in leukemia. Read more about You eat what you are: autophagy inhibition as a therapeutic strategy in leukemia.
